Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking.
Clish
C B
CB
Department of Anesthesiology, Perioperative & Pain Medicine, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Gronert
K
K
Serhan
C N
CN
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects*; D004337:Drug Carriers; D006893:Hydroxyeicosatetraenoic Acids / Q000008:administration & dosage*; D007249:Inflammation / Q000473:pathology; D044045:Lipoxins; D051379:Mice; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D004337:Drug Carriers; D006893:Hydroxyeicosatetraenoic Acids; D044045:Lipoxins; D014409:Tumor Necrosis Factor-alpha; C040527:lipoxin A4; D001241:Aspirin